New precision oncology test to identify the most effective anti-cancer treatment

Summary:

A Belgian SME active in molecular diagnostics field, in collaboration with a UK laboratory and contract research organisation, offers the most comprehensive precision oncology test able to identify the right drug for a given cancer, which increases the chances of successful treatment. The company looks for commercial agreement with technical assistance with public and private hospitals, medical centres all with oncology units, cancer centres and medical oncologists.

Reference:

TOBE20160929001

Country:

Belgium

Submitted:

November 07 2016

Updated:

November 07 2016

View Partnering Opportunity

KEYWORDS

Market:

Population genetics, Diagnostic services

Technology:

Cytology, Cancerology, Oncology, Diagnostics, Diagnosis, Gene - DNA Therapy, Genetic Engineering

NACE:

Research and experimental development on biotechnology, Specialist medical practice activities